Triple
T20759159
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ocuvite |
E510927
|
entity |
| Predicate | hasVariant |
P455
|
FINISHED |
| Object | Ocuvite Eye Health Formula |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Ocuvite Eye Health Formula | Statement: [Ocuvite, hasVariant, Ocuvite Eye Health Formula]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ocuvite Eye Health Formula Context triple: [Ocuvite, hasVariant, Ocuvite Eye Health Formula]
-
A.
EyeSight
EyeSight is Apple’s outward-facing display system on the Vision Pro headset that shows a realistic view of the wearer’s eyes to people nearby.
-
B.
Rénergie Yeux
Rénergie Yeux is an eye-care product line from Lancôme’s anti-aging Rénergie range, formulated to target wrinkles, firmness, and visible signs of aging around the eye area.
-
C.
PreserVision
chosen
PreserVision is a line of eye health dietary supplements, best known for formulations based on AREDS clinical studies to help reduce the risk of progression of age-related macular degeneration.
-
D.
Marico Eye
Marico Eye is a clear natural spring in South Africa that forms the primary headwaters of the Marico River.
-
E.
Restasis
Restasis is a prescription ophthalmic cyclosporine eye drop used to increase tear production in patients with chronic dry eye disease.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b4c909ec8190b05987f1639513f6 |
completed | April 16, 2026, 10:07 a.m. |
| NER | Named-entity recognition | batch_69e6c24751688190829f9d836abfb606 |
completed | April 21, 2026, 12:18 a.m. |
Created at: April 16, 2026, 12:35 p.m.